Bellerophon Therapeutics Inc buy Slaandjivaa
Start price
12.04.17
/
50%
€16.13
Target price
12.10.17
€40.59
Performance (%)
38.42%
End price
12.10.17
€22.32
Summary
This prediction ended on 12.10.17 with a price of €22.32. With a performance of 38.42% the BUY prediction by Slaandjivaa was a big success. Slaandjivaa has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Bellerophon Therapeutics Inc | - | - | - | - |
| iShares Core DAX® | 1.001% | -1.218% | 13.263% | 60.023% |
| iShares Nasdaq 100 | -1.447% | -4.597% | 0.414% | 85.321% |
| iShares Nikkei 225® | 8.406% | 8.425% | 27.328% | 61.038% |
| iShares S&P 500 | -0.226% | -2.451% | 0.167% | 57.738% |
Comments by Slaandjivaa for this prediction
In the thread Bellerophon Therapeutics Inc diskutieren
Slaandjivaa stimmt der Buy-Einschätzung von datca zu
Slaandjivaa stimmt am 12.04.2017 der Buy-Einschätzung von datca mit dem Kursziel 3$ zu.Überschrift: Bellerophon, erfolgreich tätig im Markt der Pulmonary Arterial Hypertension
(Laufzeit überschritten)